RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 42 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $837,977 | +39708.9% | 4,869,126 | +0.3% | 0.00% | -50.0% |
| Q3 2022 | $2,105 | -49.6% | 4,853,773 | -1.1% | 0.00% | -50.0% |
| Q2 2022 | $4,174 | -84.6% | 4,906,078 | -0.0% | 0.00% | -78.9% |
| Q1 2022 | $27,039 | -43.4% | 4,907,471 | -0.5% | 0.02% | -26.9% |
| Q4 2021 | $47,730 | -43.1% | 4,930,859 | +5.0% | 0.03% | -40.9% |
| Q3 2021 | $83,927 | -26.8% | 4,693,832 | -0.0% | 0.04% | -21.4% |
| Q2 2021 | $114,605 | -7.9% | 4,695,022 | +0.0% | 0.06% | -20.0% |
| Q1 2021 | $124,388 | +247.9% | 4,693,871 | -0.3% | 0.07% | +250.0% |
| Q4 2020 | $35,749 | +66.9% | 4,710,061 | +10.2% | 0.02% | +33.3% |
| Q3 2020 | $21,413 | -15.8% | 4,273,861 | +0.4% | 0.02% | -21.1% |
| Q2 2020 | $25,444 | +34.3% | 4,254,732 | -0.1% | 0.02% | -9.5% |
| Q1 2020 | $18,943 | -53.1% | 4,256,900 | +0.1% | 0.02% | -46.2% |
| Q4 2019 | $40,390 | +21.3% | 4,251,470 | +0.3% | 0.04% | +2.6% |
| Q3 2019 | $33,290 | -50.0% | 4,240,767 | +0.1% | 0.04% | -46.5% |
| Q2 2019 | $66,612 | -11.0% | 4,234,682 | +2.5% | 0.07% | -13.4% |
| Q1 2019 | $74,804 | +14.7% | 4,132,851 | +1.9% | 0.08% | -3.5% |
| Q4 2018 | $65,223 | -30.5% | 4,056,196 | +3.7% | 0.08% | -15.8% |
| Q3 2018 | $93,831 | – | 3,909,612 | – | 0.10% | – |
Download | ||||||